LKFT — Lakefront Biotherapeutics NV Share News
0.000.00%
Last trade - 00:00- €1.69bn
- -€1.28bn
- €1.11bn
Netherland's Galapagos to spin off innovative medicines unit (updated)
Corrected: Netherland's Galapagos to spin off innovative medicines unit
Brief: Galapagos Intends To Separate Into Two Publicly Traded Entities
Kepler cuts Galapagos on 'Pyrrhic gamble' strategy
Galapagos NV reports results for the quarter ended in September 30 - Earnings Summary
Brief: Galapagos Says 9m Net Profit Of Period EUR 48.8 Million
French and Benelux stocks-Factors to watch
Europe Research Roundup: Basler AG, Greatland Gold, Sandvik AB
U.S. RESEARCH ROUNDUP-Galapagos, Marsh & Mclennan, Travelers
Galapagos jumps after appointing EcoR1's Nodelman to its board
Brief: Galapagos Receives Transparency Notification From Ecor1 Capital
Brief: Ecor1 Capital Reports 9.9% Stake In Galapagos NV As Of Aug 19
Galapagos rises on FDA clearance for phase 1/2 ATALANTA-1 study
Brief: Galapagos: FDA Clears IND Application For Phase 1/2 ATALANTA-1 Study
Europe Research Roundup: Ashtead Group, Beazley, Entain
U.S. STOCKS ON THE MOVE-Intel, Nvidia, Chevron
U.S. STOCKS ON THE MOVE-MercadoLibre, DoorDash, Coinbase
Galapagos slips after it pauses drug candidate study
Galapagos NV reports results for the quarter ended in June - Earnings Summary